Lipidated Antimicrobial Peptides for Membrane Targeting

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antimicrobial peptides face challenges such as reduced efficacy in physiological conditions, high manufacturing costs, and the development of antibiotic resistance, necessitating the need for improved antimicrobial agents effective against both Gram-positive and Gram-negative bacteria, including antibiotic-resistant strains.

Innovation Solution

Development of lipidated peptides, specifically lipopeptides conjugated with fatty acids, which are more robust and stable, targeting bacterial membranes to inhibit bacterial growth and prevent biofilm formation, while maintaining selectivity and minimizing resistance development.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antimicrobial peptides are used, then antimicrobial activity is achieved, but efficacy is reduced in physiological conditions

Engineering Contradiction:
Improveantimicrobial efficacyVSAvoidstability in physiological conditions
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent modifies the chemical parameters of antimicrobial peptides by conjugating them to fatty acids of specific chain lengths (C8-C14) and compositions (saturated/unsaturated ratios). This parameter change enhances stability in physiological conditions while maintaining antimicrobial activity, directly resolving the contradiction between reliability and stability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite structures by combining antimicrobial peptide sequences with fatty acid moieties. These lipopeptide composites exhibit improved stability in physiological conditions compared to conventional peptides, while the peptide portion maintains the antimicrobial function, thus resolving the contradiction between reliability and stability.

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional antimicrobial peptides are used, then antimicrobial activity is achieved, but manufacturing costs are high

Engineering Contradiction:
Improveantimicrobial activityVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent optimizes peptide length parameters (truncating to 4-12 amino acids) and fatty acid chain length parameters (C8-C14) to reduce manufacturing complexity and cost. These parameter changes maintain antimicrobial activity while making the peptides more economical to produce compared to conventional longer peptides.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention employs short peptide sequences (4-12 amino acids) that are simpler and less expensive to synthesize than conventional antimicrobial peptides. The lipopeptide structure provides sufficient stability and activity, allowing cost-effective manufacturing while maintaining reliability.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If conventional antimicrobial peptides are used, then antimicrobial activity is achieved, but antibiotic resistance develops

Engineering Contradiction:
Improveantimicrobial activityVSAvoidresistance development
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent employs lipopeptides with specific local structural qualities - the fatty acid conjugation at specific positions creates localized hydrophobic regions that enhance membrane targeting. This local quality modification improves antimicrobial activity while the unique structure slows resistance development compared to conventional peptides.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention inverts the conventional approach by using shorter peptide sequences conjugated to fatty acids, rather than long peptides. This inverted structure provides effective antimicrobial activity while presenting a novel target that slows resistance development, resolving the contradiction between maintaining activity and preventing resistance.

Inventive Principle:
Principle #13The other way round (Inversion)

4Ease of manufacture

If peptide sequences are truncated to reduce cost, then manufacturing cost decreases, but antimicrobial activity is compromised

Engineering Contradiction:
Improvemanufacturing costVSAvoidantimicrobial activity
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent identifies optimal peptide length parameters (4-12 amino acids) and fatty acid chain length parameters (C8-C14) that maintain antimicrobial activity while reducing manufacturing cost. This parameter optimization resolves the contradiction between ease of manufacture and reliability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention extracts only the essential antimicrobial core sequences (4-12 amino acids) and combines them with fatty acid moieties. This extraction of essential elements maintains activity while removing non-essential portions that would increase cost, resolving the contradiction between manufacturing ease and reliability.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The lipidated peptides demonstrate enhanced antimicrobial activity against a broad spectrum of bacteria, including resistant strains, with improved stability in physiological conditions and reduced binding to serum proteins, effectively preventing biofilm formation and recruiting immune cells to clear infections.

Implementation Method 1

lipidated peptides (e.g., antimicrobial lipopeptides)...conjugated to a fatty acid...targeting bacterial membranes

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS20240294572A1Antimicrobial Peptides
Publication Date: 2024.09.05 BOARD OF RGT UNIV OF NEBRASKA
  • US20240294572A1 patent drawing
  • US20240294572A1 patent drawing
  • US20240294572A1 patent drawing

AI summary

Antimicrobial peptides and methods of use are provided.